Ark Ther Grp Share Chat - AKT
|Share Name||Share Symbol||Market||Type||Share ISIN||Share Description|
|Ark Therapeutics Group||LSE:AKT||London||Ordinary Share||GB00BSZLMS59||ORD 10P|
|Price Change||Price Change %||Share Price||Bid Price||Offer Price||High Price||Low Price||Open Price||Shares Traded||Last Trade|
|Industry Sector||Turnover (m)||Profit (m)||EPS - Basic||PE Ratio||Market Cap (m)|
|Pharmaceuticals & Biotechnology||0.0||-1.1||0.5||126.5||132.37|
ARK Therapeutics Share Discussion Threads
Showing 3650 to 3675 of 3675 messages
|Please note the thread for PVG created by pet lover on Tuesday of this week (10th. March):
"DOG AND CAT OWNERS (PVG)"
|I might even get my money back if this continues like this over the next year!!||joeblogg2|
|The free float is so small now and the BOD have huge amounts at stake.||joeblogg2|
|Raj Uppal is a very good operator, who makes money...this will do well.||errollc|
|Slowly edging up. Would buy more to bring my average down but sadly no funds as I feel they have a good model and met Rajan Uppal who has made a lot of money in his ventures and I think will do well here as has a big stake!!||joeblogg2|
|With stock so limited any good news could really see this rocket. Just checking and Barclays won't let me buy online and have to telephone them but can sell my 20k no problem as could not sell them on Friday so looks like there is a buyer.||joeblogg2|
The directors here do seem to be very good at looking after themselves.
They allowed themselves to invest in the placing at 10.1p, a discount of over 80% to the suspended share price consolidation-adjust||hedgehog 100|
|bigglesbingham - I concur. I had a contemptuous email from him some months ago and not the dignity of reply in one I sent around a month ago. It was inevitable that the share price halved when suspension lifted - I reckon a further 90% fall.
Now, I have many medical friends and know two vets very slightly. I cannot believe for a moment that their practices are loss making other than for taxation purpose. For continual losses to incur is, I suggest, easily explained with the payment of over generous drawings and the filtering of private expenses that are not wholly and necessarily incurred to run the business. A good example is the annual skiing jolly.
These are entirely allowable in full - so 3 weeks holiday in Switzerland with a series of lectures lined up in the evenings discussing advances in fractures/analgesics||erogenous jones|
|I make it 50% down on value we would have got if they had just closed company and distributed monies rather than reverse take over. Anyone disagree? Ross is inept||bigglesbingham|
|At least we are back up and running||curlly|
|Not much interest here any more :((||joeblogg2|
|TBM, any thoughts on how this will develop?||joeblogg2|
|Back trading, I will need over £2 to break even here :((||joeblogg2|
|Cynically, my take is that the time limit in suspension will be just sufficient for the remaining cash to be swallowed up in fees and emoluments.||erogenous jones|
|28/01/2015 09:29 UKREG Ark Therapeutics Group PLC Sale and Purchase Agreement Signed
"Sale and Purchase Agreement Signed
London, UK, 28 January 2015 (LSE: AKT): Ark Therapeutics Group plc ("Ark" or the "Company") announces that, as foreshadowed in the Company's announcement and in its circular to shareholders, in each case dated 21 November 2014, it has entered into a share sale and purchase agreement with Rajan Uppal, Dominic Tonner and Berkeley Burke Trustee Company Limited to acquire 75.8% of the issued share capital of Premier Veterinary Group Limited ("PVG"). The aggregate consideration payable to all PVG shareholders is GBP3,731.18 in cash. The sellers have invoked the drag-along provisions contained in PVG's articles of association to enable the Company to acquire the entire issued share capital of PVG.
Completion of the acquisition is scheduled to occur on 5 February 2015. The Company's shares will remain suspended until further notice but, as set out in the circular of 21 November 2014, it is the intention of the Company to publish a prospectus and to seek readmission of the Company's shares on the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. A further announcement will be made in due course."
|I might have touched on a nerve as there is a holding RNS issued today.||erogenous jones|
|Still no sign of prospectus, Hedghog 100. Total shambles from Ross as far as I am concerned. As for bed partner, well, little evidence so far that this is a business that is slick and organised. I warrant that a listing is simply to be able in time to raise funds rather than growing business organically. That the vetinary business is loss making, is unusual, I would have thought. Mind you, higher education is no guarantee of financial competence. Surely this cannot be so complicated a merge/takeover to take so long? Could this be regulatory, NOMAD or to squander the remaining cash to line the trousers of those claiming to have the best interests of shareholders at heart?||erogenous jones|
|On or around today:
21/11/2014 17:48 UKREG Ark Therapeutics Group PLC Posting of Circular
"10. Expected timetable of principal events
Time and/or date
... Date upon which cancellation of the 14 January 2015
premium listing category will become
Expected date of completion of the on or around 20 January
Expected date of publication of the on or around 21 January
Prospectus 2015 ...
|No sign of the prospectus. It was due to be published today.||erogenous jones|
|Another related company - and a large one - to AKT's RTO (reverse takeover) Premier Veterinary Group(PVG):
Pets At Home Group (PETS) 201.3p Market cap. £1,006.5M.
|It's just that one sees other great deals that shells have achieved, and this is what our directors have achieved - over £3 million in debt if you included the arrangement fee and final pay-off!!!!||mypension|
|I think my once 4k investment here is now worth £40. Can't say that I am going to lose any sleep on this one way or another. I'd rather it carried on as a listed company so at least if I did come to sell them I would be able to write them off against my other booming investments (that I hasten to point out I have not yet found).||dr biotech|